Cwm LLC Raises Stake in GRAIL, Inc. (NASDAQ:GRAL)

CWM LLC grew its stake in shares of GRAIL, Inc. (NASDAQ:GRAL - Free Report) by 248.3% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 22,715 shares of the company's stock after purchasing an additional 16,193 shares during the period. CWM LLC owned approximately 0.06% of GRAIL worth $580,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in GRAL. State of Tennessee Department of Treasury acquired a new position in shares of GRAIL during the 4th quarter worth $28,000. Caldwell Sutter Capital Inc. acquired a new position in shares of GRAIL during the 1st quarter worth $28,000. Sterling Capital Management LLC acquired a new position in shares of GRAIL during the 4th quarter worth $29,000. KBC Group NV raised its stake in shares of GRAIL by 187.7% during the 1st quarter. KBC Group NV now owns 1,430 shares of the company's stock worth $37,000 after buying an additional 933 shares during the last quarter. Finally, S.A. Mason LLC raised its stake in shares of GRAIL by 50.1% during the 1st quarter. S.A. Mason LLC now owns 1,499 shares of the company's stock worth $38,000 after buying an additional 500 shares during the last quarter.

Insider Activity

In other news, CEO Robert P. Ragusa sold 94,035 shares of GRAIL stock in a transaction dated Friday, May 2nd. The shares were sold at an average price of $33.93, for a total transaction of $3,190,607.55. Following the completion of the sale, the chief executive officer directly owned 734,627 shares in the company, valued at $24,925,894.11. The trade was a 11.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Aaron Freidin sold 8,000 shares of GRAIL stock in a transaction dated Tuesday, July 15th. The stock was sold at an average price of $38.93, for a total transaction of $311,440.00. Following the sale, the chief financial officer owned 286,020 shares of the company's stock, valued at approximately $11,134,758.60. This trade represents a 2.72% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 540,890 shares of company stock valued at $23,868,412. 1.85% of the stock is owned by corporate insiders.

GRAIL Price Performance

NASDAQ:GRAL traded up $0.57 on Friday, reaching $40.29. The stock had a trading volume of 551,688 shares, compared to its average volume of 1,320,343. GRAIL, Inc. has a 12-month low of $12.33 and a 12-month high of $63.99. The company has a market cap of $1.45 billion and a price-to-earnings ratio of -0.66. The firm's fifty day moving average is $41.84 and its two-hundred day moving average is $35.00.

GRAIL (NASDAQ:GRAL - Get Free Report) last issued its quarterly earnings results on Tuesday, May 13th. The company reported ($3.10) EPS for the quarter, topping analysts' consensus estimates of ($4.03) by $0.93. The business had revenue of $31.84 million during the quarter, compared to the consensus estimate of $35.80 million. GRAIL had a negative net margin of 1,464.53% and a negative return on equity of 17.99%. As a group, research analysts forecast that GRAIL, Inc. will post -15.15 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group lifted their price target on GRAIL from $32.00 to $43.00 and gave the stock a "buy" rating in a research note on Wednesday, May 14th.

GRAIL Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.